Leadership Transition at Dentsply Sirona as Simon Campion Steps Down, Daniel Scavilla Takes the Helm

gas_fee_therapist · 2026-02-19T10:12:26+00:00

Dentsply Sirona Inc. has announced Simon Campion's departure as CEO, effective July 31, 2025, with Daniel Scavilla taking over on August 1. Scavilla's leadership experience in the medical device sector aligns with the company's growth strategy. Additionally, strong Q2 financial results signal market confidence, with projected sales of $935 million. The leadership change is seen as a strategic move to enhance operational performance and ensure continued stability.

gas_fee_therapist

2026-02-19 10:12:26

Abstract generation in progress

Dentsply Sirona Inc. (XRAY) has announced a significant leadership change, with Simon Campion departing from his role as President and Chief Executive Officer effective July 31, 2025. Daniel Scavilla assumes the CEO position beginning August 1, 2025, bringing extensive healthcare industry experience from his previous tenure as President and CEO of Globus Medical, Inc. (GMED).

New CEO Brings Medical Device Leadership Expertise

Daniel Scavilla’s transition to Dentsply Sirona represents a strategic leadership move within the medical device sector. His background at Globus Medical, a prominent spine and orthopedic solutions provider, positions him to navigate the global dental equipment market. The appointment underscores the company’s commitment to maintaining executive continuity while driving future growth under fresh vision and leadership.

Strong Q2 Financial Performance Signals Market Confidence

Concurrently with the leadership announcement, Dentsply Sirona disclosed preliminary financial results for the second quarter ending June 30, 2025. The company projected net sales of approximately $935 million with adjusted earnings per share ranging from $0.50 to $0.52. These financial metrics reflect solid operational performance during the period. In response to the combined developments, XRAY shares traded in the pre-market session at $16, gaining 2.04 percent on the Nasdaq, suggesting investor confidence in both the financial trajectory and the new management direction under Daniel Scavilla’s leadership, as Simon Campion’s departure marks the conclusion of his tenure.

Market Outlook Under New Direction

The CEO transition, while marking the end of Simon Campion’s leadership chapter at Dentsply Sirona, positions the company for the next phase of strategic execution. With established quarterly performance demonstrating revenue stability and profitability, the organization enters this transition period from a position of operational strength.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes